Ralaniten (EPI-002) is an effective and orally active androgen receptor N-terminal domain (AR-NTD) antagonist. Ralaniten inhibits AR transcriptional activity,IC50 The value is 7.4 µM. Ralanites can be used in the study of castration-resistant prostate cancer (CRPC).
Molecular Weight:
394.89
Purity:
>99%
CAS Number:
[1203490-23-6]
Formula:
C21H27ClO5
Target:
Androgen Receptor
* VAT and and shipping costs not included. Errors and price changes excepted